Skip to content
Nonprofiteer
← CARING CROSS INC

Form 990 for tax year 2024

Filed by CARING CROSS INC.

Totals

Total revenue
$6,365,843
Total expenses
$10,310,690
Contributions and grants received
$3,773,205
Grants paid
$5,529
Program service revenue
$1,339,248
Investment income
$373,031
Other revenue
$880,359
Total assets, end of year
$16,467,907
Total liabilities, end of year
$5,991,534
Net assets or fund balances, end of year
$10,476,373
Program services expenses (Part IX)
$7,675,809
Management and general expenses
$2,634,881
Fundraising expenses
$0
Program service expenses (Part III)
$7,675,809

Program services were 74.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $1,772,453

  • 1f · All other contributions, gifts and grants

    $2,000,752

  • 2a · Program service revenue: REVENUE FROM SERVICES

    total $1,334,248 · related or exempt $1,334,248

  • 2b · Program service revenue: NON-INVENTORY SALES

    total $5,000 · related or exempt $5,000

  • 3 · Investment income

    total $375,523 · excluded $375,523

  • 6a · Gross rents

    real property $880,359

  • 6b · Less rental expenses

    real property $0

  • 6c · Rental income or loss

    real property $880,359

  • 6d · Net rental income or loss

    total $880,359 · related or exempt $880,359

  • 7a · Gross sales of assets other than inventory

    other assets $1,549

  • 7b · Less cost or other basis and sales expenses

    other assets $4,041

  • 7c · Gain or loss

    other assets -$2,492

  • 7d · Net gain or loss

    total -$2,492 · excluded -$2,492

Functional expenses

Part IX, the statement of functional expenses.

  • 3 · Grants to foreign organizations and individuals

    total $5,529 · program services $5,529

  • 5 · Compensation of officers, directors and key employees

    total $850,148 · program services $840,144 · management and general $10,004

  • 7 · Other salaries and wages

    total $2,565,619 · program services $2,079,628 · management and general $485,991

  • 9 · Other employee benefits

    total $217,342 · program services $178,539 · management and general $38,803

  • 10 · Payroll taxes

    total $241,282 · program services $205,455 · management and general $35,827

  • 11b · Fees: legal

    total $34,167 · management and general $34,167

  • 11c · Fees: accounting

    total $21,123 · management and general $21,123

  • 11g · Fees: other

    total $465,532 · program services $215,002 · management and general $250,530

  • 13 · Office expenses

    total $413,182 · program services $106,598 · management and general $306,584

  • 14 · Information technology

    total $102,811 · program services $6,508 · management and general $96,303

  • 16 · Occupancy

    total $1,459,318 · program services $183,536 · management and general $1,275,782

  • 17 · Travel

    total $50,460 · program services $24,559 · management and general $25,901

  • 19 · Conferences, conventions and meetings

    total $40,847 · program services $11,099 · management and general $29,748

  • 20 · Interest

    total $5,696 · program services $315 · management and general $5,381

  • 22 · Depreciation, depletion and amortization

    total $402,580 · program services $395,476 · management and general $7,104

  • 23 · Insurance

    total $11,633 · management and general $11,633

  • 24a · Other expenses: LAB SUPPLIES & MATERIAL

    total $3,423,421 · program services $3,423,421

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $134,069 · end of year $432,133

  • 2 · Savings and temporary cash investments

    beginning of year $12,757,302 · end of year $5,725,401

  • 4 · Accounts receivable

    beginning of year $1,170,906 · end of year $420,054

  • 9 · Prepaid expenses and deferred charges

    beginning of year $335,587 · end of year $172,408

  • 10a · Land, buildings and equipment: cost or other basis

    $5,357,603

  • 10b · Land, buildings and equipment: accumulated depreciation

    $752,818

  • 10c · Land, buildings and equipment, net

    beginning of year $1,118,943 · end of year $4,604,785

  • 11 · Investments: publicly traded securities

    beginning of year $100 · end of year $0

  • 14 · Intangible assets

    beginning of year $13,261 · end of year $18,426

  • 15 · Other assets

    beginning of year $0 · end of year $5,094,700

  • 17 · Accounts payable and accrued expenses

    beginning of year $983,565 · end of year $459,429

  • 25 · Other liabilities

    beginning of year $0 · end of year $5,532,105

  • 27 · Net assets without donor restrictions

    beginning of year $14,533,004 · end of year $10,462,773

  • 28 · Net assets with donor restrictions

    beginning of year $13,599 · end of year $13,600

Mission and programs · 2024

Mission

CARING CROSS IS FOCUSED UPON ACCELERATING THE DEVELOPMENT AND IMPLEMENTATION OF ADVANCED MEDICINES LIKE CAR-T CELL AND STEM CELL GENE THERAPIES. IN PARTNERSHIP WITH LIKE-MINDED STAKEHOLDERS, CARING CROSS DEVELOPS AND DEPLOYS TECHNOLOGIES, SYSTEMS AND THERAPEUTIC CANDIDATES THAT IMPROVE THE AFFORDABILITY AND ACCESSIBILITY OF THESE POTENTIALLY LIFE-SAVING THERAPIES FOR ALL PATIENTS IN NEED, EVERYWHERE.

Activities or mission (Part I)

FOCUSED UPON ACCELERATING THE DEVELOPMENT AND IMPLEMENTATION OF ADVANCED MEDICINES

  • UNIVERSITY OF DELAWARE: NIIMBL RESEARCH DEVELOPMENT, AND TESTBEDS TO HELP THE NATION PREVENT, PREPARE FOR AND RESPOND TO CORONAVIRUS.

    Expenses $5,530,229 · Grants $5,529 · Revenue $2,219,607

  • TOME BIOSCIENCES AND CARING CROSS INC. RESEARCH COLLABORATION

    Expenses $1,365,313

  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ON BEHALF OF ITS SAN FRANCISCO CAMPUS "UCSF": COMPLETE THE PHASE I IIA CLINICAL TRIAL DEVELOP A COMMERCIAL MANUFACTURING PROCESS AND DEVELOP A REGULATORY PATHWAY PLAN FOR DECENTRALIZED FDA APPROVAL OF THE ANTI-HIV DUOCAR-T CELL PRODUCT.

    Expenses $780,267

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Boro Dropulic PhD MBA

    EXEC DIR., FOUNDER, PRESIDENT

    Total calculated
    $151,686
    From this org
    $144,119
    From related orgs
    $0
    Other
    $7,567
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $144,119
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $7,567
    Filer's total
    $151,686
  • Rimas Orentas PhD End 92024

    SCIENTIFIC DIR., FOUNDER, SEC, PRES

    Total calculated
    $250,112
    From this org
    $226,676
    From related orgs
    $0
    Other
    $23,436
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $210,592
    Bonus
    $0
    Other
    $16,084
    Deferred
    $4,534
    Nontaxable benefits
    $18,902
    Filer's total
    $250,112
  • Zhongyu Zhu

    CHIEF SCIENCE OFFICER

    Total calculated
    $226,058
    From this org
    $226,058
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $226,058
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $226,058
  • Megan Forrest

    CHIEF OPERATING OFFICER

    Total calculated
    $222,292
    From this org
    $199,365
    From related orgs
    $0
    Other
    $22,927
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $199,365
    Bonus
    $0
    Other
    $0
    Deferred
    $317
    Nontaxable benefits
    $22,610
    Filer's total
    $222,292
  • Beatrix Ferencz

    ASSOC. DIR. OF PROCESS DEVELOPMENT

    Total calculated
    $184,371
    From this org
    $157,526
    From related orgs
    $0
    Other
    $26,845
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $157,526
    Bonus
    $0
    Other
    $0
    Deferred
    $3,088
    Nontaxable benefits
    $23,757
    Filer's total
    $184,371
  • Ibe Oparaocha

    DIRECTOR OF PROCESS DEVELOPMENT

    Total calculated
    $160,645
    From this org
    $153,078
    From related orgs
    $0
    Other
    $7,567
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $153,078
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $7,567
    Filer's total
    $160,645
  • Kara Anlauf

    SCIENCE RESOURCES AND COMMUNICATIONS

    Total calculated
    $151,351
    From this org
    $145,555
    From related orgs
    $0
    Other
    $5,796
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $145,555
    Bonus
    $0
    Other
    $0
    Deferred
    $2,769
    Nontaxable benefits
    $3,027
    Filer's total
    $151,351
  • Ying Xiong

    DIRECTOR OF CELL & GENE THERAPY

    Total calculated
    $157,682
    From this org
    $135,903
    From related orgs
    $0
    Other
    $21,779
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $135,903
    Bonus
    $0
    Other
    $0
    Deferred
    $2,877
    Nontaxable benefits
    $18,902
    Filer's total
    $157,682
  • Oxana Slessareva

    DIR. OF QUALITY SYSTEMS DEVELOPMENT

    Total calculated
    $134,182
    From this org
    $127,203
    From related orgs
    $0
    Other
    $6,979
    Hours/week
    40
  • Jennifer Adair PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Lindsay Androski JD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Nicanor Austriaco Op PhD Std

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Deus Bazira Drph MPH MBA

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Mark Dybul MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • James Kenny MBA

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Xiaobin Lu PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Crystal Mackall MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Julie Makani MD PhD Frcp Ftaas

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Mike McCune MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Tom Rosedale JD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Barbara Savoldo MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Nirav Shah MD Mshp

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • Joshua Speidel PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2024
Filed
14 November 2025
IRS schema version
2024v5.2
Source object
202513189349314771

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.